ResearcherUniversity of Cape TownActive in the last 2 years
Marc M. Bernon
Matched on ORCID iD 0000-0002-7967-8548; OpenAlex author ID A5073992917. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 3 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers
Papers 6
- Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1494446↗
- Preoperative risk factors for 90-day postoperative mortality in patients with pancreatic ductal adenocarcinoma: a cohort-based study. Co-author DOI 10.36303/sajs.02398↗
- Audit of an in-patient palliative care quality improvement process for patients with pancreatic ductal adenocarcinoma in a South African teaching hospital. Co-author PMID 38838124↗
- Letter to the Editor: Comment on: Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy. Last author DOI 10.1007/s12029-021-00656-4↗
- Letter comments re: Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A NCDB analysis. Co-author DOI 10.1016/j.ejca.2021.09.001↗
- Survival equivalence in patients treated for borderline resectable and unresectable locally advanced pancreatic ductal adenocarcinoma: a systematic review and … Co-author DOI 10.1016/j.hpb.2020.09.022↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eduard Jonas · 6 shared papers, 2021–2025 · strength 1.32
- Paper Preoperative risk factors for 90-day postoperative mortality in patients with pancreatic ductal adenocarcinoma: a cohor… DOI 10.36303/sajs.02398↗
- Paper Audit of an in-patient palliative care quality improvement process for patients with pancreatic ductal adenocarcinoma i… PMID 38838124↗
- Paper Letter to the Editor: Comment on: Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combin… DOI 10.1007/s12029-021-00656-4↗
- Urda K. Kotze · 4 shared papers, 2021–2025 · strength 0.91
- Paper Preoperative risk factors for 90-day postoperative mortality in patients with pancreatic ductal adenocarcinoma: a cohor… DOI 10.36303/sajs.02398↗
- Paper Audit of an in-patient palliative care quality improvement process for patients with pancreatic ductal adenocarcinoma i… PMID 38838124↗
- Paper Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal a… DOI 10.3389/fimmu.2025.1494446↗
- Jake E.J. Krige · 3 shared papers, 2021 · strength 0.57
- Paper Letter to the Editor: Comment on: Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combin… DOI 10.1007/s12029-021-00656-4↗
- Paper Letter comments re: Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A NCDB ana… DOI 10.1016/j.ejca.2021.09.001↗
- Paper Survival equivalence in patients treated for borderline resectable and unresectable locally advanced pancreatic ductal … DOI 10.1016/j.hpb.2020.09.022↗
- Christo Kloppers · 2 shared papers, 2025 · strength 0.50
- Paper Preoperative risk factors for 90-day postoperative mortality in patients with pancreatic ductal adenocarcinoma: a cohor… DOI 10.36303/sajs.02398↗
- Paper Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal a… DOI 10.3389/fimmu.2025.1494446↗
- Jessica D. Lindemann · 2 shared papers, 2021 · strength 0.35
- Paper Letter comments re: Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A NCDB ana… DOI 10.1016/j.ejca.2021.09.001↗
- Paper Survival equivalence in patients treated for borderline resectable and unresectable locally advanced pancreatic ductal … DOI 10.1016/j.hpb.2020.09.022↗
- Clara-Marie Clasen · 1 shared paper, 2025 · strength 0.28
- Haytham Bayadsi · 1 shared paper, 2025 · strength 0.28
- Pamela Winnie M. Maimela · 1 shared paper, 2025 · strength 0.21
- Jonathan Michael Blackburn · 1 shared paper, 2025 · strength 0.21
- Metoboroghene Oluwaseyi Mowoe · 1 shared paper, 2025 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.